Feridun KARAKURT, Ayşe ÇARLIOĞLU, Recep AKGEDİK, Zeki YILDIRIM, Bülent BOZKURT, Ayşe IŞIK, Faruk TURGUT

İzole sternum kırığı ile prezente olan primer hiperparatiroidizm olgusu

Primer hiperparatiroidizm (PHPT); parathormonun (PTH) aşırı sekresyonu sonucu hiperkalsemi ile karekterize yaygın bir endokrin bozukluktur. Görülme sıklığı 65 yaş üzerinde 1/1000 olup kadınlarda 2-3 kat daha fazladır. Hastaların %80’inden fazlası asemptomatiktir ve sıklıkla rasgele saptanan yüksek kalsiyum değerleri olması ile tanı alırlar. Semptomatik hastaların çoğunda halsizlik, bitkinlik ve kolay yorulma şikayetleri ve aşikar kemik hastalığı, fraktürler veya nefrolitiazis bulunur. Biz yazımızda izole sternum kırığı ile başvuran primer hiperparatiroidi olgusunu sunduk.

Presented with isolated sternal fracture primary hyperparathyroidism case

Primary hyperparathyroidism is a common disorder characterized by hypercalcemia as a result of parathormon oversecretion. its frequency over 65 years is 1/1000 and is 2 to 3 times more common in females. More than 80% of the patients are asymptomatic and are usually diagnosed with incidentally detected high serum calcium levels. Most of the symptomatic patients present with fatigue, weakness and exhaustion and with overt bone disease, fractures or nephrolithiasis. We presented applied isolated sternal fracture with primary hyperparathyroidism case.

PDF

___

1. Kearns AE, Thompson GB. Medical and surgical management of hyperparathyroidism. Mayo Clin Proc 2002;77: 87-91.
2. Mihai R, Farndon JR. Parathyroid disease and calcium metabolism. Br J Anaesth. 2000;85: 29-43.
3. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10 year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999;34: 1249–55.
4. Potts JT Jr. Diseases of the parathyroid gland and other hyper and hypocalcemic disorders. In: Harrison TR, Braunwald E. Harrison’s Principles of internal medicine. 15th ed. New York: McGraw-Hill 2001:8-22.
5. Bilezikian JP, Brandi ML, Rubin M, Silverberg SJ. Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. J Intern Med. 2005;257: 6-17.
6. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001;86: 5658–71.
7. Simonds WF, James-Newton LA, Agarwal SK, Yang B, Skarulis MC, Hendy GN, Marx SJ. Familial isolated hyperparathyroidism: clinical and genetic characteristics of thirty-six kindreds. Medicine (Baltimore) 2002;81: 1–26.
8. Bilezikian JP, Potts JT Jr, Fuleihan Gel-H, Kleerekoper M, Neer R, Peacock M, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 2002;17: N2-11.
9. Silverberg SJ. Natural history of primary hyperparathyroidism. Endocrinol Metab Clin North Am 2000;29: 451-64.
10. Parisien M, Mellish RW, Silverberg SJ, Shane E, Lindsay R, Bilezikian JP, et al. Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis. J Bone Miner Res 1992;7: 913–19.
11. Zahrani A, Levine MA. Primary hyperparathyroidism. Lancet 1997;349: 1233–8.
12. 45. National Institutes of Health. Consensus development conference statement on primary hyperparathyroidism. J Bone Miner Res 1991;6: 9–13.
13. Mosekilde L. Primary hyperparathyroidism and the skeleton. Clin Endocrinol (Oxf). 2007 Dec 20.
14. Bilezikian JP, Potts JT Jr, Fuleihan Gel-H, Kleerekoper M, Neer R, Peacock M, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 2002;87: 5353–61.
15. VanderWalde LH, Liu I.L, O’Connell TX, Haigh PI. The effect of parathyroidectomy on bone fracture risk in patients with primary hyperparathyroidism. Archives of Surgery 2006;141: 885–91.